ACTHAR Therapy for Central Nervous System Sarcoidosis

Summary

There is a need for a more reliable, expeditious therapy that can be used as an alternative to glucocorticoids in severe Central Nervous System (CNS) sarcoidosis. This study aims to provide evidence for effectiveness of ACTHAR gel in CNS sarcoidosis, and provide information about its safety and tolerability

Timeline

Start

2019-02-01

Primary completion

2020-11-02

Completion

2020-11-02

Drugs

Indications